Skip to main content

Stannous Chloride in the Preparation of 99mTc Pharmaceuticals

  • Chapter
Technetium-99m Pharmaceuticals

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alberto R, Abram U (2003) 99mTc: labeling chemistry and labeled compounds. In: Vertés A, Nagy S, Klenscár Z (eds) Radiochemistry and radiopharmaceutical chemistry in life science, handbook of nuclear chemistry, vol. 4. Kluwer, Dordrecht, pp 211–256

    Google Scholar 

  • Alvarez J (1975) Radiopharmaceuticals prepared with stannous chloride. J Radioanal Chem 27:475–482

    Article  CAS  Google Scholar 

  • Banerjee T, Singh AK, Sharma RK, Maitra AN (2005) Labelling efficiency and biodistribution of technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles. Int J Pharm 289:189–195

    Article  PubMed  CAS  Google Scholar 

  • Benjamin PP (1969) A rapid and efficient method of preparing 99mTc-human serum albumin: its clinical applications. Int J Appl Radiat Isot 20:187–194

    Article  PubMed  CAS  Google Scholar 

  • Benjamin PP, Rejali A, Friedell H (1970) Electrolytic complexation of 99mTc at constant current: its application in nuclear medicine. J Nucl Med 11:147–154

    PubMed  CAS  Google Scholar 

  • Clarke MJ, Podbielski L (1987) Medical diagnostic imaging with complexes of 99mTc. Coord Chem Rev 78:253–331

    Article  CAS  Google Scholar 

  • Deutsch ME, Redmond ML (1972) Unitary freeze-dried kits for preparation of technetium-labeled human serum albumin. J Nucl Med 13(Abstr):426–427

    Google Scholar 

  • Deutsch E, Elder RC, Lange BA, Vaal MJ, Lay DG (1976) Structural characterization of a bridged 99Tc-Sn-dimethylglyoxime complex — implications for chemistry of 99mTc-radiopharmaceuticals prepared by Sn(II) reduction of pertechnetate. Proc Natl Acad Sci USA 73:4289

    Article  Google Scholar 

  • Deutsch E, Libson K, Becker CB (1980) Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion. J Nucl Med 21:859–866

    PubMed  CAS  Google Scholar 

  • Deutsch E, Glavan KA, Sodd VJ (1981) Cationic 99mTc complexes as potential myocardial imaging agents. J Nucl Med 22:897–907

    PubMed  CAS  Google Scholar 

  • Donaldson JD, Moser W (1960) Pure tin(II) sulfate. J Chem Soc 4000–4003

    Google Scholar 

  • Dreyer R, Münze R (1969) Markierung von Serumalbumin mit 99mTechnetium [in German]. Wiss Z Karl Marx Univ Leipzig, Math-Naturwiss R 18:629–633

    CAS  Google Scholar 

  • Dworkin HJ, Gutkowski RF (1971) Rapid closed system production of 99mTc-albumin using electrolysis. J Nucl Med 12:562–565

    PubMed  CAS  Google Scholar 

  • Eckelman WC, Richards P (1970) Instant 99mTc-DTPA. J Nucl Med 11:761–762

    PubMed  CAS  Google Scholar 

  • Eckelman WC, Meinken G, Richards P (1971a) Chemical state of 99mTc in biomedical products. J Nucl Med 12:596–600

    PubMed  CAS  Google Scholar 

  • Eckelman WC, Meinken G, Richards P (1971b) 99mTc-human serum albumin. J Nucl Med 12:707–710

    PubMed  CAS  Google Scholar 

  • Eckelman WC, Richards P (1972) Analytical pitfalls with 99mTc-labelled compounds. J Nucl Med 13:202–204

    PubMed  CAS  Google Scholar 

  • Eckelman WC, Steigman J (1991) Direct labelling with 99mTc. Nucl Med Biol 18:3–7

    CAS  Google Scholar 

  • Fischer HW (1957) Colloidal stannic oxide — animal studies on a new hepatolienographic agent. Radiology 68:488–498

    PubMed  CAS  Google Scholar 

  • Gil MC, Palma T, Radicella R (1976) Electrolytical labelling of 99mTc-radiopharmaceuticals. Int J Appl Radiat Isot 27:69

    Article  PubMed  CAS  Google Scholar 

  • Greenland WEP, Fogelman I, Blower PJ (2002) Direct labelling via simultaneous reduction of pertechnetate and a disulfide bond. In: Nicolini M, Mazzi U (eds) Tc, Re and other metals in chemistry and nuclear medicine 6. SG Editoriali, Padova, Italy, pp 495–498

    Google Scholar 

  • Hoffmann I, May K, Noll B (1990) Determination of tin(II) concentration in ROTOP MAG-3 kit. Zentralinstitut Kernforschung Rossendorf, Dresden, Annual Report ZfK 711:46–47

    Google Scholar 

  • Kalincak M, Machan V, Vilcek S (1982) 99mTc-labelled compounds prepared with Ti(III) as reducing agent. Isotopenpraxis 18:334–338

    CAS  Google Scholar 

  • Kremer C, Leon A, Gambino D (1989) Solid-phase reduction of (TcC −4 )-99mTc with zinc — a method for the preparation of difficult 99mTc compexes. J Labelled Comp Radiopharm 27:1331–1340

    Article  CAS  Google Scholar 

  • Lejeune R, Thunus J, Thunus L (1996) Polarographic determination of (Sn(II) in samples containing Sn(IV) such as in technetium-99m radiopharmaceutical kits. Anal Chim Acta 332:67–71

    Article  CAS  Google Scholar 

  • Lin SM, Winchell HS, Shipley BA (1971) Use of Fe(II) or Sn(II) alone for technetium labelling of albumin. J Nucl Med 12:204–211

    PubMed  CAS  Google Scholar 

  • Münze R (1980) Electrochemical investigation on the reduction of 99TcO −4 with tin(II) in the presence of citrate. Radiochem Radioanal Lett 43:219–224

    Google Scholar 

  • Nakayama M, Terahara T, Wada M, Ginoza Y, Harada K, Sugii A, Nakayama H (1995) Insoluble macromolecular Sn(II) complex for the 99mTc labelling of protein-bearing mercapto groups. In: Nicolini M, Mazzi U (eds) Tc, Re and other metals in chemistry and nuclear medicine 4. SG Editoriali, Padova, Italy, pp 299–320

    Google Scholar 

  • Noronha OPD (1978) Time-dependent characteristics on Sn-complexes for preparing 99mTc-labelled radiopharmaceuticals and their bioavailabilities — a review. Nuklearmedizin 17:110–125

    PubMed  CAS  Google Scholar 

  • Novotnik DP (1990) Physico-chemical concepts in the preparation of technetium radiopharmaceuticals. In: Sampson CB (ed) Textbook of radiopharmacy: theory and practice. Gordon and Breach, Philadelphia, pp 29–49

    Google Scholar 

  • Persson RBR, Liden K (1969) 99mTc-labelled human serum albumin — a study of labelling procedure. Int J Appl Radiat Isot 20:241

    Article  PubMed  CAS  Google Scholar 

  • Rakias F, Zolle I (1997) Stannous ion determination: importance and relevance for radiopharmaceutical kits. In: Bergmann H, Kroiss A, Sinzinger H (eds) Radioactive isotope in clinical medicine and research, vol. 22. Birkhauser, Basel, pp 401–409

    Google Scholar 

  • Rhodes BA (1991) Direct labelling of proteins with 99mTc. Nucl Med Biol 18:667–676

    CAS  Google Scholar 

  • Schwochau K (2000) Technetium — chemistry and radiopharmaceutical applications. Wiley, New York, p 44

    Google Scholar 

  • Smith JE, Byrne EF, Cotton FA (1978) Thiol complex of technetium pertinent to radiopharmaceutical use of 99mTc. J Amer Chem Soc 100:5571–5572

    Article  CAS  Google Scholar 

  • Spies H, Johannsen B, Münze R, Unverferth K (1978) Die Reduktion von Pertechnetat mit Cystein [in German]. Z Anorg Allg Chem 447:215–220

    Article  CAS  Google Scholar 

  • Srivastava SC, Meinken G, Smith TD, Richards P (1977) Problems associated with stannous 99mTc-radiopharmaceuticals. Int J Appl Radiat Isot 28:83–95

    Article  PubMed  CAS  Google Scholar 

  • Srivastava SC, Richards P (1983) Technetium-labelled compounds. In: Rayudu GVS (ed) Radiotracers for medical applications, CRC series in radiotracers in bioliology and medicine. CRC Press, Boca Raton, pp 107–185

    Google Scholar 

  • Steigman J, Eckelman WC, Meinken G, Isaacs HS, Richards P (1974) The chemistry of technetium labeling of radiopharmaceuticals by electrolysis. J Nucl Med 15:75–80

    PubMed  CAS  Google Scholar 

  • Steigman J, Richards P (1974) The chemistry of technetium. Sem Nucl Med 4:269–279

    Article  CAS  Google Scholar 

  • Steigman J, Meinken G, Richards P (1975) The reduction of pertechnetate-99 by stannous chloride-I. The stoichiometry of the reaction in HC1, in a citrate buffer and in a DTPA buffer. Int J Appl Radiat Isot 26:601–609

    Article  CAS  Google Scholar 

  • Stern HS, Zolle I, McAfee JG (1965) Preparation of 99mTc-labelled serum albumin. Int J Appl Radiat Isot 16:283–288

    Article  PubMed  CAS  Google Scholar 

  • Subramanian G, McAfee JG (1970) Stannous oxide colloid labeled with 99mTc or 113mIn for bone marrow imaging. J Nucl Med 11:365–366

    Google Scholar 

  • Syhre R, Spies H, Johannsen B (1976) Die Organverteilung von 99mTc(Sn)-Hydroxidkolloid in der Ratte in Abhängigkeit vom Präparations-pH [in German]. Radiobiol Radiother 17:747–750

    CAS  Google Scholar 

  • Thomas RW, Estes GW, Elder RC (1979) Technetium radiopharmaceutical development. I. Synthesis, characterization and structure of dichloro[hydrotris(l-pyrazolyl)borate]oxo-technetium(V). J Amer Chem Soc 101:4581

    Article  CAS  Google Scholar 

  • Vanderheyden JL, Ketring AR, Libson K, Heeg MJ, Roecker L, Motz P, Whittle R, Elder RC, Deutsch E (1984) Synthesis and characterization of cationic technetium complexes of l,2-bis(dimethylphosphino)ethane (DMPE) — structure determinations of trans-[Tc-(DMPE)2(OH)(O)](F3CSO3)2, trans-[Tc-III(DMPE)2CL2]F3CSO3 and [Tc-I(DMPE)3]+ using x-ray-diffraction, EXAFS and 99Tc NMR. Inorg Chem 23:3184–3191

    Article  CAS  Google Scholar 

  • Vilcek S, Kalincak M, Machan V (1982) Analysis of 99mTc-labelled compounds using Sorb-Gel method. Radiochem Radioanal Lett 52:55–64

    CAS  Google Scholar 

  • Vilcek S, Machan V, Kalincak M (1984) 99mTc-labelled compounds prepared with molybdenum(III) as reducing agent. Int J Appl Radiat and Isot 35:228–230

    Article  CAS  Google Scholar 

  • Vilcek S, Kalincak M, Machan V (1985) 99mTc-labelled compounds prepared with tungsten(III) as the reducing agent. J Radioanal Nucl Chem 88:359–367

    Article  CAS  Google Scholar 

  • Wardell JL (1994) Tin: inorganic chemistry. In: King RB (ed) Encyclopedia of inorganic chemistry, vol. 8. Wiley, New York, pp 4159–4197

    Google Scholar 

  • Yokoyama A, Kominami G, Harada S (1975) The role of ascorbic acid with the ferric ion in labelling human serum albumin with 99mTc. Int J Appl Radiat Isot 26:291–299

    Article  PubMed  CAS  Google Scholar 

  • Zolle I, Oniciu L, Höfer R (1973) Contribution to the study of the mechanism of labelling human serum albumin (HSA) with Technetium-99m. Int J Appl Radiat Isot 24:621–626

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Spies, H., Pietzsch, H.J. (2007). Stannous Chloride in the Preparation of 99mTc Pharmaceuticals. In: Zolle, I. (eds) Technetium-99m Pharmaceuticals. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33990-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33990-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33989-2

  • Online ISBN: 978-3-540-33990-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics